A phase 2, double-blind, placebo-controlled trial of a valproate/lithium combination in ALS patients
Background: Few treatments are currently available for amyotrophic lateral sclerosis (ALS). A combination of lithium carbonate and valproic acid (VPA-Li) was shown to inhibit motor neuron death and delay disease progression. Methods: Outpatients with a typical ALS presentation were enrolled in a ran...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Espanhol |
| Опубліковано: |
Elsevier España
2025-01-01
|
| Серія: | Neurología |
| Предмети: | |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S0213485322000779 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|